Publication | Open Access

Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study

Hematological MalignancyMedicineHematologyMyeloid NeoplasiaLiposomal DoxorubicinMultiple MyelomaPharmacotherapyOncologyRadiation OncologyT-vad DoxilHealth Sciences